{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:26:48Z","timestamp":1786771608938,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbadis.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T07:59:54Z","timestamp":1428566394000},"page":"2336-2338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"PB","title":["Future perspectives: Moving towards NCL treatments"],"prefix":"10.1016","volume":"1852","author":[{"given":"Susan L.","family":"Cotman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Mole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Kohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbadis.2015.04.001_bb0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium","volume":"82","author":"International Batten Disease Consortium","year":"1995","journal-title":"Cell"},{"issue":"6541","key":"10.1016\/j.bbadis.2015.04.001_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/376584a0","article-title":"Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis","volume":"376","author":"Vesa","year":"1995","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.bbadis.2015.04.001_bb0015","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1007\/s00216-013-7061-4","article-title":"Recent advances in metabolomics in neurological disease, and future perspectives","volume":"405","author":"Zhang","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"issue":"7","key":"10.1016\/j.bbadis.2015.04.001_bb0020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","article-title":"Metabolomics of human brain aging and age-related neurodegenerative diseases","volume":"73","author":"Jove","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2015.04.001_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2015.01.001","article-title":"Application of metabolomics in autoimmune diseases: insight into biomarkers and pathology","volume":"279C","author":"Kang","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"15","key":"10.1016\/j.bbadis.2015.04.001_bb0030","first-page":"2346","article-title":"Induction of pluripotent stem cells from mouse fibroblast cultures","volume":"51","author":"Yamanaka","year":"2006","journal-title":"Tanpakushitsu Kakusan Koso"},{"issue":"8","key":"10.1016\/j.bbadis.2015.04.001_bb0035","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/hmg\/ddt596","article-title":"Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway","volume":"23","author":"Lojewski","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bbadis.2015.04.001_bb0040","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"9","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.001_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2008.04.022","article-title":"Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis","volume":"213","author":"Sondhi","year":"2008","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.001_bb0050","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.001_bb0055","first-page":"324","article-title":"Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile Neuronal Ceroid Lipofuscinosis. Hum. Gene Ther","volume":"23","author":"Sondhi","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.bbadis.2015.04.001_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.001_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","article-title":"Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis","volume":"114","author":"Vuillemenot","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.bbadis.2015.04.001_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"20","key":"10.1016\/j.bbadis.2015.04.001_bb0075","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1212\/WNL.0b013e318237f649","article-title":"Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"77","author":"Kwon","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbadis.2015.04.001_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cct.2013.04.004","article-title":"Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates","volume":"35","author":"de Blieck","year":"2013","journal-title":"Contemp. Clin. Trials"},{"issue":"4","key":"10.1016\/j.bbadis.2015.04.001_bb0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/dmcn.12634","article-title":"Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis","volume":"57","author":"Augustine","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"issue":"12","key":"10.1016\/j.bbadis.2015.04.001_bb0090","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the Parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2015.04.001_bb0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajhg.2012.05.023","article-title":"A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system","volume":"91","author":"Staropoli","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.bbadis.2015.04.001_bb0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:37:42Z","timestamp":1786768662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443915001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0925443915001076"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.001","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future perspectives: Moving towards NCL treatments","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}